CLARISE MBA: Open Payments
NPI 1376305631 · OWINGS MILLS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$712 in 7 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $27 · 2025 $712
Food & beverage: $712
| Company | Payments | Amount |
|---|---|---|
| Medline Industries LP | 1 | $205 |
| Organogenesis Inc. | 2 | $193 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $112 |
| Teva Pharmaceuticals USA, Inc. | 1 | $105 |
| HARTMANN USA, INC. | 1 | $75 |
| Solventum Corporation | 1 | $23 |
Products named: APLIGRAF, CAPLYTA, UZEDY, ZETUVIT PLUS 10X10 P10, ACTIV.A.C..
Industry payments across MD — which companies pay providers there.
